Elicera Therapeutics Completes Phase I of CARMA Study
Elicera Therapeutics completed the Phase I part of its CARMA study.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Elicera Therapeutics completed the Phase I part of its CARMA study.